CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 115 filers reported holding CHINA BIOLOGIC PRODS INC in Q4 2015. The put-call ratio across all filers is 1.08 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $326,108,000 | -6.9% | 3,256,848 | +0.0% | 0.10% | -9.6% |
| Q4 2016 | $350,138,000 | -10.0% | 3,256,496 | +4.2% | 0.11% | -11.6% |
| Q3 2016 | $389,110,000 | +20.7% | 3,125,885 | +3.1% | 0.13% | +17.3% |
| Q2 2016 | $322,325,000 | +32.4% | 3,031,654 | +42.5% | 0.11% | +31.0% |
| Q1 2016 | $243,531,000 | +426.0% | 2,127,277 | +554.5% | 0.08% | +425.0% |
| Q4 2015 | $46,300,000 | – | 325,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPQ Asia Capital Ltd | 287,277 | $35,760,000 | 28.32% |
| WARBURG PINCUS LLC | 6,674 | $830,780,000 | 13.45% |
| Ariose Capital Management Ltd | 238,841 | $27,689,000 | 7.56% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 12,600 | $1,568,000 | 4.48% |
| RUDMAN ERROL M | 37,001 | $4,606,000 | 3.72% |
| INDUS CAPITAL PARTNERS, LLC | 245,237 | $30,527,000 | 2.89% |
| Ativo Capital Management LLC | 93,784 | $11,674,000 | 2.70% |
| OBERWEIS ASSET MANAGEMENT INC/ | 63,305 | $7,880,000 | 2.27% |
| Point72 Hong Kong Ltd | 31,500 | $3,921,000 | 2.14% |
| Cormorant Asset Management, LP | 112,867 | $14,050,000 | 1.55% |